186 related articles for article (PubMed ID: 6688487)
21. [Chemotherapy of lymphogranulomatosis].
Schmidt CG
Internist (Berl); 1974 Feb; 15(2):93-102. PubMed ID: 4600311
[No Abstract] [Full Text] [Related]
22. The therapy of Hodgkin's disease in Nigeria: a five year study.
Oluboyede OA; Esan GJ
Afr J Med Med Sci; 1976 Sep; 5(3):201-7. PubMed ID: 829730
[TBL] [Abstract][Full Text] [Related]
23. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
24. [Treatment of recurrences of lymphogranulomatosis].
Kovryzhkina TA
Med Radiol (Mosk); 1984 Jan; 29(1):35-9. PubMed ID: 6546406
[No Abstract] [Full Text] [Related]
25. [Chemotherapy of Hodgkin disease with modified MOPP].
Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F
Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638
[No Abstract] [Full Text] [Related]
26. Management of Hodgkin's disease.
Desforges JF; Rutherford CJ
Compr Ther; 1979 Feb; 5(2):63-9. PubMed ID: 428209
[No Abstract] [Full Text] [Related]
27. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Fiacchini M; Lauria F; Mazza P; Tura S
Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
[No Abstract] [Full Text] [Related]
29. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
30. [Treatment of lymphogranulomatosis].
Baĭsogolov GD
Med Radiol (Mosk); 1982 Sep; 27(9):83-9. PubMed ID: 6897278
[No Abstract] [Full Text] [Related]
31. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's disease in Indian children: outcome with chemotherapy alone.
Arya LS; Dinand V; Thavaraj V; Bakhshi S; Dawar R; Rath GK; Singh R; Vats TS
Pediatr Blood Cancer; 2006 Jan; 46(1):26-34. PubMed ID: 16161019
[TBL] [Abstract][Full Text] [Related]
33. [Long-term remission in advanced stages of lymphogranulomatosis following combined chemotherapy using a modified de Vita system].
Wilmanns W; Wilms K; Koos T
Hamatol Bluttransfus; 1976; 18():109-18. PubMed ID: 964705
[No Abstract] [Full Text] [Related]
34. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
35. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
[No Abstract] [Full Text] [Related]
36. [Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
Zhou L; Wang Q; Feng F
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):333-5. PubMed ID: 11778565
[TBL] [Abstract][Full Text] [Related]
37. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
38. [Hodgkin's disease in childhood: long term results].
Cramer P; Schaison G; Andrieu JM; Boiron M; Bernard J
Arch Fr Pediatr; 1982 Apr; 39(4):223-9. PubMed ID: 6896975
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy of Hodgkin's disease in children.
Kolygin BA
Cancer; 1976 Oct; 38(4):1494-7. PubMed ID: 991072
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
Klumb CE; Carriço MK; de Rezende LM; Byington R; Bordallo MA; Bigni RS; Apa AG; Dobbin JA
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):628-9. PubMed ID: 17662581
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
